Health

3 UX Trends Shaping Healthcare in 2021

The healthcare industry continues to evolve its use of smart devices, ranging from wearable technology to remote monitoring, but with innovation brings new obstacles in meeting patients’ needs.  As...

read more

The time for a better UX in digital therapeutics is now

If history has shown that payer behavior tends to shift once a critical mass has been achieved, and we are on the precipice of achieving that critical mass for digital therapeutics, having a “user friendly solution” is about to replace “having a reimbursable solution” as the #1 factor affecting physician prescribing behavior.

read more

3 UX Trends Shaping Healthcare in 2021

The healthcare industry continues to evolve its use of smart devices, ranging from wearable technology to remote monitoring, but with innovation brings new obstacles in meeting patients’ needs.  As UX researchers and designers, we have played a key role in helping design solutions to these complex...

read more

Human factors research in the times of COVID

How to continue to support development of safe and effective medical devices Many thought pieces are being pushed out around what remote research methods are available to replace research that would have otherwise been conducted in person if not for COVID. We’ve published some ourselves (Three...

read more

Is FMEA inadequate for human factors analyses?

As part of the overall human factors effort associated with the development of a medical device, critical tasks1 must be determined and evaluated. To support testing of critical tasks related to a device, it is necessary to have a clear understanding of the hazards associated with use of the...

read more

Reclassifying diabetes: 3 implications for product design

Currently, diabetes is diagnosed as either Type 1 or Type 2 (setting aside gestational diabetes). Research has suggested that diabetes should be reclassified into multiple separate diseases; a group of scientists in Scandinavia argues for 5 (where others argue for as many as 11). Either way, one...

read more

The time for a better UX in digital therapeutics is now

If history has shown that payer behavior tends to shift once a critical mass has been achieved, and we are on the precipice of achieving that critical mass for digital therapeutics, having a “user friendly solution” is about to replace “having a reimbursable solution” as the #1 factor affecting physician prescribing behavior.

read more